The Neuroepidemiological Transition in Brazil: Nationwide Trends in Cerebrovascular, Dementia, Alzheimer’s, and Parkinson’s Mortality, 2000–2024
International Journal of Environmental Research and Public Health · 2026-11-07 · 23 (11) · 1400
DOI: 10.3390/ijerph23111400 ↗Abstract
Neurological mortality may change through population ageing, shifts in age-specific mortality, and changes in diagnostic ascertainment and death certification. We examined recorded underlying-cause mortality from cerebrovascular disease, dementia, Alzheimer’s disease, and Parkinson’s disease in Brazil from 2000 to 2024. We analyzed 30,593,956 death records from the Brazilian Mortality Information System. Age-standardized mortality rates (ASMRs) were calculated using the WHO World Standard Population and modeled with inverse-variance-weighted piecewise log-linear regression. We additionally derived a study-specific descriptive Neuroepidemiological Transition Index (NTI), defined as dementia/cerebrovascular ASMR, and applied Shapley decomposition. Cerebrovascular mortality declined from 63.69 to 36.88 per 100,000 (average annual percentage change [AAPC] −2.17%; 95% CI, −2.29 to −2.05), whereas dementia increased from 1.75 to 11.39 (AAPC +8.04%), Alzheimer’s disease from 1.24 to 9.74 (+9.18%), and Parkinson’s disease from 0.81 to 2.11 (+4.05%). The NTI increased from 0.028 to 0.309 (AAPC +10.59%; 95% CI, 10.27–10.91). In the Shapley decomposition, 63.8% of the increase in dementia deaths was assigned to changes in age-specific recorded mortality rates, compared with 27.3% for population ageing and 9.0% for population growth. Brazil showed a marked shift in the composition of recorded neurological mortality, with implications for vascular prevention, dementia risk reduction, healthy ageing, and long-term care.
EUVIMED